Oxolinic acid is a quinolone antibiotic that was developed in Japan in the 1970s. It acts by inhibiting the enzyme DNA gyrase, which is essential for bacterial DNA replication.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 14698-29-4
Nalidixic acid
pharmaceutical raw material
Diphenhydramine hydrochloride
pharmaceutical raw material
Cytarabine
pharmaceutical raw material
[1-(2-Phenylethyl)-1h-imidazol-2-yl]-4-piperidinylmethanone dihydrobromide
pharmaceutical raw material
(1-methylpiperidin-4-yl)(1-phenethyl-1H-imidazol-2-yl)methanone
pharmaceutical raw material
Sodium oxolinate
pharmaceutical raw material
5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
KYGZCKSPAKDVKC-UHFFFAOYSA-N
CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O